Nucleotide Sequences
QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 2313059 | Bss55 | Bone structure and strength QTL 55 | 3.2 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 70209 | Niddm23 | Non-insulin dependent diabetes mellitus QTL 23 | 2.82 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 94494440 | 198324465 | Rat | 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat | 1582234 | Gluco18 | Glucose level QTL 18 | 3.4 | 0.0003 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 78479925 | 123479925 | Rat | 1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 30882023 | 123479925 | Rat | 634314 | Niddm44 | Non-insulin dependent diabetes mellitus QTL 44 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 49393289 | 199050459 | Rat | 1578780 | Cm52 | Cardiac mass QTL 52 | 3.3 | 0.0001 | heart mass (VT:0007028) | heart wet weight (CMO:0000069) | 1 | 81591954 | 219808434 | Rat | 1331793 | Bp200 | Blood pressure QTL 200 | 3.71601 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 94494440 | 172949803 | Rat | 1578654 | Bss10 | Bone structure and strength QTL 10 | 4 | femur morphology trait (VT:0000559) | femoral neck cortical cross-sectional area (CMO:0001702) | 1 | 49393172 | 159356837 | Rat | 2300324 | Fetw1 | Fetal weight QTL 1 | 12.1 | 0.005 | fetal growth trait (VT:0004201) | fetal body weight (CMO:0002080) | 1 | 85424647 | 100358001 | Rat | 1300121 | Hrtrt1 | Heart rate QTL 1 | 3.7 | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 65789093 | 115540829 | Rat | 1331800 | Scl25 | Serum cholesterol level QTL 25 | 3.013 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 1 | 94494440 | 117601394 | Rat | 7421628 | Bp361 | Blood pressure QTL 361 | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 66023617 | 118608521 | Rat | 631495 | Bp96 | Blood pressure QTL 96 | 4.52 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat | 70225 | Bp58 | Blood pressure QTL 58 | 3.3 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32356093 | 162846471 | Rat | 2298545 | Neuinf8 | Neuroinflammation QTL 8 | 4.6 | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 1 | 57336763 | 151090257 | Rat | 2313072 | Bss53 | Bone structure and strength QTL 53 | 4.3 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 43284731 | 118944897 | Rat | 10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32737458 | 199368955 | Rat | 2313078 | Bss54 | Bone structure and strength QTL 54 | 3.5 | 0.0001 | tibia area (VT:1000281) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat | 1302788 | Scl19 | Serum cholesterol QTL 19 | 4.6 | 0.001 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 1 | 90532338 | 123479925 | Rat | 1549903 | Bp267 | Blood pressure QTL 267 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 77876254 | 106047988 | Rat | 2313083 | Bmd74 | Bone mineral density QTL 74 | 4 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 82174743 | 118944897 | Rat | 2313402 | Anxrr24 | Anxiety related response QTL 24 | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 1 | 48963584 | 144267916 | Rat | 4889494 | Scort2 | Serum corticosterone level QTL 2 | 4.2 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 1 | 80592172 | 125592172 | Rat | 724567 | Tcas6 | Tongue tumor susceptibility QTL 6 | 6.85 | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 1 | 92948896 | 144267916 | Rat | 61342 | Bp27 | Blood pressure QTL 27 | 3.4 | 0.0006 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 56732668 | 98773277 | Rat | 61344 | Bp29 | Blood pressure QTL 29 | 7.5 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 78350581 | 123350581 | Rat | 724521 | Uae1 | Urinary albumin excretion QTL 1 | 3.8 | 0.0001 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 1 | 90508614 | 173018436 | Rat | 1358902 | Bw47 | Body weight QTL 47 | 1.67 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 90508614 | 180359386 | Rat | 1358192 | Ept13 | Estrogen-induced pituitary tumorigenesis QTL 13 | 3.4 | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 1 | 77494165 | 122494165 | Rat | 2313094 | Bss58 | Bone structure and strength QTL 58 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 43284731 | 118944897 | Rat | 2300164 | Bmd44 | Bone mineral density QTL 44 | 5.4 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 1 | 56949932 | 101949932 | Rat | 2313099 | Bss56 | Bone structure and strength QTL 56 | 2.4 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft endosteal cross-sectional area (CMO:0001716) | 1 | 43284731 | 118944897 | Rat | 2313098 | Bmd70 | Bone mineral density QTL 70 | 3.6 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 43284731 | 118944897 | Rat | 1300153 | Bp171 | Blood pressure QTL 171 | 3.37 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 90664883 | 143200202 | Rat | 731168 | Bp154 | Blood pressure QTL 154 | 3.4 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 94642644 | 214537671 | Rat | 738022 | Anxrr13 | Anxiety related response QTL 13 | 4.6 | 0.00039 | locomotor behavior trait (VT:0001392) | number of 20 x 20 cm floor squares crossed into, out of or within a discrete space in an experimental apparatus (CMO:0001514) | 1 | 83547917 | 128547917 | Rat | 152025249 | Scl82 | Serum cholesterol level QTL 82 | 4.77 | blood cholesterol amount (VT:0000180) | 1 | 50343510 | 99980958 | Rat | 10054135 | Gmadr2 | Adrenal mass QTL 2 | 1.97 | 0.0129 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 77857876 | 122857876 | Rat | 7411712 | Strs4 | Sensitivity to stroke QTL 4 | 8.7 | cerebrum integrity trait (VT:0010549) | percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932) | 1 | 78430536 | 123430536 | Rat | 1331749 | Hrtrt11 | Heart rate QTL 11 | 2.973 | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 94494440 | 198211706 | Rat | 1331751 | Bp199 | Blood pressure QTL 199 | 3.60022 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 94494440 | 181830018 | Rat | 2293142 | Bp314 | Blood pressure QTL 314 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 92184926 | 137184926 | Rat | 2313051 | Bss57 | Bone structure and strength QTL 57 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 43284731 | 118944897 | Rat | 724529 | Cm16 | Cardiac mass QTL 16 | 2.7 | heart mass (VT:0007028) | calculated heart weight (CMO:0000073) | 1 | 87580395 | 150700247 | Rat | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Information